Thomas L. Wegman, President

Mr. Wegman has served as an officer at BioSpecifics for over 20 years and has been a member of the Board of Directors since 1994. He has over 35 years of experience in the biopharmaceutical industry managing company operations, drug development, licensing and registration. Mr. Wegman managed the production, marketing and foreign registration activities related to an avian vaccine business, Biota NV. Mr. Wegman has been instrumental in licensing technologies from universities for use by BioSpecifics. He is the author of a number of U.S. and foreign patents in the field of life sciences that have led to the successful commercialization of injectable collagenase for multiple indications and have the potential to support new therapeutic indications. He is a graduate of Boston University.